Scientists of Max Planck Institute for Molecular Genetics have reconstructed chromosomes of patients with a high number of aberrations in their genome that potentially cause disease
Hunting for disease clues in the dark matter of our DNA
ABL SA group acquires Berlin based Medtech company Humedics
ABL SA acquires the company Humedics Gmbh to extend the use of a robust, well-known, and CE-marked technology intended to be used for liver function measurement. Financial terms are not disclosed.
Female Founders Award 2023 | Apply or Nominate Now!
On April 26, 2023, the American Chamber of Commerce in Germany (AmCham Germany) will present its Female Founders Award for the fourth time in Berlin.
Announcement of the Winners of the 2022 CAAT Humane Education Award
Congratulations to Dr. Vivian Kral and Dr. Christian Zoschke from Free University Berlin, Germany, who won the 2022 CAAT Humane Education Award for their project titled “3Rs Info Hub PRO - Your go-to place for training on non-animal research”.
Each…
Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power
Bayer to speed up its in-silico research and development with Google Cloud’s high-speed processors / Collaboration aims to enable Bayer to run large quantum chemistry calculations at scale using Google Tensorflow Processing Units
Metabolism expert joins Charité to advance understanding of age-related diseases
Prof. Dr. Michael Ristow is the new director of the Institute of Experimental Endocrinology
On January 1, Michael Ristow became tenured Professor of Experimental Endocrinology and Diabetology at Charité – Universitätsmedizin Berlin. His research…
ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
ProBioGen announced today a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen's DirectedLuck® transposase technology.
ProBioGen and Boehringer Ingelheim have a long legacy of fruitful collaboration going back to 2011, when the…
ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
ProBioGen announced today a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen's DirectedLuck® transposase technology.
Prof. Dr. Joachim Spranger is the new Dean of Charité
Prof. Pries hands over office to Prof. Spranger at official ceremony
Prof. Dr. Joachim Spranger took over as Dean of Charité – Universitätsmedizin Berlin on January 1, 2023. His new role comes with a seat on Charité’s Board of Directors, where he is…